Back to Dashboard
QGEN · Healthcare

Qiagen N.v.

Europe Healthcare
Market cap
$9.0B
Industry
Diagnostics & Research
Sector
Healthcare
Exchange
NYSE
About Qiagen N.V.

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It…

Congressional trades · 4 on record
Disclosures from 2019-01-09 to 2020-03-24
The newest disclosure we hold for this stock is 2020-03-24. That is the end of our data, not necessarily the end of the trading — our bulk STOCK Act archive stops there and newer filings arrive through a separate live feed. Treat the absence of recent rows as “not covered”, not as “no trades”.
Trade date Member Chamber Action Amount
2020-03-24 Peter Welch · D-VT House Sold $1,001 - $15,000
2020-02-27 Peter Welch · D-VT House Bought $1,001 - $15,000
2019-01-23 Donna E. Shalala · D-FL House Sold $1,001 - $15,000
2019-01-09 Donna E. Shalala · D-FL House Sold $1,001 - $15,000
Not in our coverage. Qiagen N.V. isn't currently held by any of the 50 hedge funds we track. The price chart and company profile below come from public Yahoo Finance data.
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell Qiagen N.V. or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订